The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,189.00
Bid: 1,189.00
Ask: 1,189.50
Change: 6.00 (0.51%)
Spread: 0.50 (0.042%)
Open: 1,200.00
High: 1,205.00
Low: 1,187.50
Prev. Close: 1,183.00
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Jan 2020 07:00

RNS Number : 5079A
Sage Group PLC
22 January 2020
 

 

Trading update for the three months ended 31 December 2019

The Sage Group plc (the "Group") is today issuing its trading update for the three months ended 31 December 2019.

Financial performance

Organic [1] Revenue Mix

Q1 FY20

Q1 FY19

Growth

£m

£m

£m

%

Revenue by Category

Recurring Revenue

£410m

£370m

+£40m

+10.7%

Other Revenue (SSRS [2] & Processing)

£55m

£65m

-£10m

-15.8%

Organic Total Revenue

£465m

£435m

+£30m

+6.7%

Portfolio View of Recurring Revenue

Future Sage Business Cloud opportunity

£362m

£321m

+£41m

+12.7%

Other (no current path to migration)

£48m

£49m

-£1m

-2.5%

Recurring Revenue

£410m

£370m

+£40m

+10.7%

 

[1] All numbers throughout this document are organic unless otherwise stated. Organic results exclude contributions from assets held for sale (Sage Pay and the Brazilian business). Full definitions are available in the FY19 results announcement.

[2] Software and software-related services.

 

Group recurring revenue increased by 10.7% to £410m, underpinned by software subscription growth of 24.8% to £286m (Q1 19: £229m), as Sage continued to focus on migrating existing customers and attracting new customers to subscription and the cloud.

Recurring revenue growth was driven principally by North America and Northern Europe (UK & Ireland), with strong momentum from FY19 carried forward into the first quarter. In North America, recurring revenue grew by 11.8% to £154m (Q1 19: £137m), driven by cloud connected solutions and a good performance from Sage Intacct. Northern Europe continued to grow strongly with recurring revenue growth of 15.1% to £93m (Q1 19: £80m), benefitting from strong growth in the second half of FY19 as well as new Sage 50 cloud connected contracts added in the quarter.

In terms of the portfolio view of revenue, the Future Sage Business Cloud Opportunity (products within, or to be migrated to, Sage Business Cloud) delivered recurring revenue growth of 12.7% to £362m, offset by a slight decrease in recurring revenue of 2.5% to £48m in products with no current path to Sage Business Cloud.

Other revenue (SSRS and processing) declined by 15.8% to £55m, in line with our expectations for the quarter, reflecting the managed decline in licence sales and de-prioritisation of professional services revenue as the business continues to focus on subscription.

Total Group revenue increased by 6.7% to £465m.

Jonathan Howell, Chief Financial Officer, commented:

"Sage had a strong first quarter as expected. We have sustained last year's growth momentum into the first quarter of FY20, as we continue to focus on driving recurring revenue through the transition to cloud-based subscription services, in line with our vision to become a great SaaS company. Looking ahead, we reiterate our guidance for the full year, as outlined in the FY19 results announcement."

Foreign exchange

Sterling strengthened in the quarter against international currencies, particularly the Euro, leading to exchange rate headwinds. 

Analyst and investor conference call

Jonathan Howell, CFO will be hosting a conference call at 8:30am GMT today which will be webcast from a link on our investor relations website, www.sage.com/investors. The call may also be accessed using the dial-in number 0800 376 7922 (United Kingdom) or +44 (0) 2071 928 000 (International) and pin code 8796118. A replay of the call will also be available for one week after the event: dial-in number 0844 571 8951 (United Kingdom) or +44 (0) 3333 009 785 (International), pin code 8796118.

 

Enquiries

The Sage Group plc +44(0) 191 294 3457

Jonathan Howell, Chief Financial Officer

Lauren Wholley, Investor Relations

James Sandford, Investor Relations

Amy Lawson, Media

FTI Consulting +44(0) 20 3727 1000

Charles Palmer

Dwight Burden

 

About Sage

Sage (FTSE: SGE) is a global market leader for technology that helps small and medium businesses perform at their best. Sage is trusted by millions of customers worldwide to deliver the best cloud technology and support, with our partners, to manage finances, operations, and people. We believe in doing everything we can to help people be the best they can be, so the combined efforts of 13,000 Sage colleagues working with businesses and communities make a real difference to the world. Sage. Perform at your Best.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAPFFAELEEFA
Date   Source Headline
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding
18th Aug 202210:19 amRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSSage to acquire Lockstep
2nd Aug 20227:00 amRNSTrading update for nine months ended 30 June 2022
29th Jul 20224:04 pmRNSTotal Voting Rights
22nd Jul 20229:02 amRNSDirectorate Change
30th Jun 20224:10 pmRNSTotal Voting Rights
24th Jun 20224:34 pmRNSDirector/PDMR Shareholding
16th Jun 20223:38 pmRNSDirector/PDMR Shareholding
8th Jun 20224:48 pmRNSDirector/PDMR Shareholding
8th Jun 20229:00 amRNSDirector Declaration
7th Jun 20222:53 pmRNSDirector/PDMR Shareholding
6th Jun 20222:00 pmRNSBlock listing Interim Review
31st May 20225:09 pmRNSTotal Voting Rights
25th May 20225:24 pmRNSDirector/PDMR Shareholding
19th May 20225:36 pmRNSDirector/PDMR Shareholding
19th May 20225:20 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSResults for the 6 months to 31 March 22 unaudited
29th Apr 20224:10 pmRNSTotal Voting Rights
31st Mar 20223:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.